Pig liver trial offers temporary lifeline for liver failure patients
Disease control
Not yet recruiting
This early-stage study tests a genetically-modified pig liver used outside the body to temporarily take over liver functions for people with acute-on-chronic liver failure. About 20 adults who are not eligible for a transplant will receive this treatment for a short time. The goa…
Phase: PHASE1 • Sponsor: eGenesis, INC • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC